Leukemic erythroderma with elevated plasma IL-3 and hyperhistaminemia: in situ expression of IL-3 mRNA in leukemic cells

J Dermatol Sci. 1995 Nov;10(3):224-8. doi: 10.1016/0923-1811(95)00408-k.

Abstract

We report a case of chronic myelogenous leukemia (CML) with pruritic erythroderma. Hyperhistaminemia, elevated level of plasma interleukin-3 (IL-3), and moderate basophilia were noted in this case. His skin manifestation was resistant to topical corticosteroid therapy and exacerbated in parallel with leukocyte count, plasma histamine and IL-3 levels. To identify localization and production of IL-3 in our case, we performed in situ hybridization on peripheral blood cells and skin biopsy specimen, and detected IL-3 mRNA in myelogenic cells in both specimens.

Publication types

  • Case Reports

MeSH terms

  • Dermatitis, Exfoliative / blood*
  • Dermatitis, Exfoliative / etiology*
  • Histamine / blood*
  • Humans
  • In Situ Hybridization
  • Interleukin-3 / blood*
  • Interleukin-3 / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Male
  • Middle Aged
  • RNA, Messenger / metabolism

Substances

  • Interleukin-3
  • RNA, Messenger
  • Histamine